16.6 Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

16.6 Somatostatin inhibits the release of:
A. Growth hormone
B. Insulin
C. Thyrotropin
D. All of the above
by

1 Answer

Answer :

D. All of the above
by

Related questions

3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Description : 3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

Last Answer : 3- Somatostatin inhibits the release of: A. Growth hormone B. Insulin C. Thyrotropin D. All of the above

16.8 Drugs that suppress growth hormone release in acromegaly include the following except: A. Bromocriptine B. Somatostatin C. Octreotide D. Nafarelin

Description : 16.8 Drugs that suppress growth hormone release in acromegaly include the following except: A. Bromocriptine B. Somatostatin C. Octreotide D. Nafarelin

Last Answer : D. Nafarelin

6.4 Several actions of growth hormone are exerted through the elaboration of: A. Cyclic AMP B. Cyclic GMP C. Somatostatin D. Insulin like growth factor-1

Description : 6.4 Several actions of growth hormone are exerted through the elaboration of: A. Cyclic AMP B. Cyclic GMP C. Somatostatin D. Insulin like growth factor-1

Last Answer : D. Insulin like growth factor-1

16.18 Thyrotropin exerts the following actions on the thyroid gland except: A. Increases vascularity B. Inhibits proteolysis of thyroglobulin C. Induces hyperplasia and hypertrophy D. Promotes iodide trapping

Description : 16.18 Thyrotropin exerts the following actions on the thyroid gland except: A. Increases vascularity B. Inhibits proteolysis of thyroglobulin C. Induces hyperplasia and hypertrophy D. Promotes iodide trapping

Last Answer : B. Inhibits proteolysis of thyroglobulin

16.5 Octreotide is a long acting synthetic analogue of: A. Prolactin B. Growth hormone C. Somatostatin D. Gonadotropin releasing hormone

Description : 16.5 Octreotide is a long acting synthetic analogue of: A. Prolactin B. Growth hormone C. Somatostatin D. Gonadotropin releasing hormone

Last Answer : D. All of the above

The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also inhibits the release of insuline and

Description : The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also inhibits the release of insuline and

Last Answer : The hormone somatostatin is resposible for inhibiting the motility and absobtion in the digestive tract. It also ... Alph B. Beta C. Delta D. F cells

Glucagon release from pancreas is stimulated by: A. High blood glucose level B. Insulin C. Somatostatin D. Adrenaline

Description : Glucagon release from pancreas is stimulated by: A. High blood glucose level B. Insulin C. Somatostatin D. Adrenaline

Last Answer : D. Adrenaline

Thyrotropin exerts the following actions on the thyroid gland except: A. Increases vascularity B. Inhibits proteolysis of thyroglobulin C. Induces hyperplasia and hypertrophy D. Promotes iodide trappin

Description : Thyrotropin exerts the following actions on the thyroid gland except: A. Increases vascularity B. Inhibits proteolysis of thyroglobulin C. Induces hyperplasia and hypertrophy D. Promotes iodide trappin

Last Answer : B. Inhibits proteolysis of thyroglobulin

Diazoxide is an effective hypotensive, but is not used in the long-term treatment of hypertension because: A. It impairs glucose tolerance by inhibiting insulin release B. It inhibits uric acid excretion C. It causes marked Na+ and water retention leading to development of tolerance D. All of the above

Description : Diazoxide is an effective hypotensive, but is not used in the long-term treatment of hypertension because: A. It impairs glucose tolerance by inhibiting insulin release B. It inhibits uric acid ... causes marked Na+ and water retention leading to development of tolerance D. All of the above

Last Answer : D. All of the above

Growth hormone is released by (A) Somatostatin (B) Growth hormone releasing hormone (C) Prolactin release inhibiting hormone (D) Luteinizing releasing hormone

Description : Growth hormone is released by (A) Somatostatin (B) Growth hormone releasing hormone (C) Prolactin release inhibiting hormone (D) Luteinizing releasing hormone

Last Answer : Answer : B

A nonapeptide among the following is (A) Antidiuretic hormone (B) Insulin (C) ACTH (D) Thyrotropin releasing hormone

Description : A nonapeptide among the following is (A) Antidiuretic hormone (B) Insulin (C) ACTH (D) Thyrotropin releasing hormone

Last Answer : Answer : A

A pheromone is A) an endorphin released within the anterior pituitary. B) a growth factor related to the production of tumors. C) a product of a neurosecretory cell that acts on neighboring cells. D) a chemical released by one animal to affect the behavior of another animal. E) a regulatory hormone that stimulates or inhibits the release of hormones produced by other endocrine glands.

Description : A pheromone is A) an endorphin released within the anterior pituitary. B) a growth factor related to the production of tumors. C) a product of a neurosecretory cell that acts on ... ) a regulatory hormone that stimulates or inhibits the release of hormones produced by other endocrine glands.

Last Answer : D) a chemical released by one animal to affect the behavior of another animal.

The metabolism of sodium is regulated by the hormone: (A) Insulin (B) Aldosterone (C) PTH (D) Somatostatin

Description : The metabolism of sodium is regulated by the hormone: (A) Insulin (B) Aldosterone (C) PTH (D) Somatostatin

Last Answer : Answer : B

The following hypothalamic regulatory hormone is not a peptide: A. Growth hormone release inhibitory hormone B. Prolactin release inhibitory hormone C. Gonadotropin releasing hormone D. Corticotropin releasing hormone (

Description : The following hypothalamic regulatory hormone is not a peptide: A. Growth hormone release inhibitory hormone B. Prolactin release inhibitory hormone C. Gonadotropin releasing hormone D. Corticotropin releasing hormone (

Last Answer : B. Prolactin release inhibitory hormone

A. It is a clonidine congener used in spasticity due to stroke or spinal injury B. It reduces muscle tone by activating GABAB receptors C. It inhibits release of excitatory amino-acids in spinal interneurones D. It reduces muscle spasms without producing weaknes

Description : A. It is a clonidine congener used in spasticity due to stroke or spinal injury B. It reduces muscle tone by activating GABAB receptors C. It inhibits release of excitatory amino-acids in spinal interneurones D. It reduces muscle spasms without producing weaknes

Last Answer : B. It reduces muscle tone by activating GABAB receptors

Acromegaly results due to excessive release of (A) Thyroxine (B) Growth hormone (C) Insulin (D) Glucagon

Description : Acromegaly results due to excessive release of (A) Thyroxine (B) Growth hormone (C) Insulin (D) Glucagon

Last Answer : Answer : B

Release of free fatty acids from adipose tissue is increased by all of the following except (A) Glucagon (B) Epinephrine (C) Growth hormone (D) Insulin

Description : Release of free fatty acids from adipose tissue is increased by all of the following except (A) Glucagon (B) Epinephrine (C) Growth hormone (D) Insulin

Last Answer : Answer : D

Secretion of somatotrophin is promoted by (A) Somatomedin C (B) Somatostatin (C) Growth hormone releasing hormone (D) Hypoglycaemia

Description : Secretion of somatotrophin is promoted by (A) Somatomedin C (B) Somatostatin (C) Growth hormone releasing hormone (D) Hypoglycaemia

Last Answer : Answer : C

Secretion of growth hormone is inhibited by (A) Somatomedin C (B) Somatostatin (C) Feedback inhibition(D) All of these

Description : Secretion of growth hormone is inhibited by (A) Somatomedin C (B) Somatostatin (C) Feedback inhibition(D) All of these

Last Answer : Answer : B

Trapping of iodide by the following organ/organs is enhanced by thyrotropin: A. Thyroid B. Salivary gland C. Placenta D. All of the abov

Description : Trapping of iodide by the following organ/organs is enhanced by thyrotropin: A. Thyroid B. Salivary gland C. Placenta D. All of the abov

Last Answer : A. Thyroid

17.1 Trapping of iodide by the following organ/organs is enhanced by thyrotropin: A. Thyroid B. Salivary gland C. Placenta D. All of the abov

Description : 17.1 Trapping of iodide by the following organ/organs is enhanced by thyrotropin: A. Thyroid B. Salivary gland C. Placenta D. All of the abov

Last Answer : A. Thyroid

16.3 Actions of growth hormone include the following except: A. Increased protein synthesis B. Increased fat utilization C. Increased carbohydrate utilization D. Glucose intolerance

Description : 16.3 Actions of growth hormone include the following except: A. Increased protein synthesis B. Increased fat utilization C. Increased carbohydrate utilization D. Glucose intolerance

Last Answer : C. Increased carbohydrate utilization

Long-term thiazide therapy can cause hyperglycaemia by: A. Reducing insulin release B. Interfering with glucose utilization in tissues C. Increasing sympathetic activity D. Increasing corticosteroid secretion

Description : Long-term thiazide therapy can cause hyperglycaemia by: A. Reducing insulin release B. Interfering with glucose utilization in tissues C. Increasing sympathetic activity D. Increasing corticosteroid secretion

Last Answer : A. Reducing insulin release

he following is true of nifedipine except: A. It can aggravate urine voiding difficulty in elderly males with prostatic hypertrophy B. It promotes Na+ retention by a renal tubular action to cause ankle oedema as side effect C. It can inhibit insulin release from pancreas D. At high doses it can paradoxically increase the frequency of angina pectori

Description : he following is true of nifedipine except: A. It can aggravate urine voiding difficulty in elderly males with prostatic hypertrophy B. It promotes Na+ retention by a renal tubular action to ... release from pancreas D. At high doses it can paradoxically increase the frequency of angina pectori

Last Answer : B. It promotes Na+ retention by a renal tubular action to cause ankle oedema as side effect

Which of the following is not a sulfonylurea but acts by analogous mechanism to bring about quick and brief insulin release that is useful for normalizing meal time glycaemic excursions in type 2 diabetes mellitus: A. Glimepiride B. Miglitol C. Repaglinide D. Rosiglitazone

Description : Which of the following is not a sulfonylurea but acts by analogous mechanism to bring about quick and brief insulin release that is useful for normalizing meal time glycaemic excursions in type 2 diabetes mellitus: A. Glimepiride B. Miglitol C. Repaglinide D. Rosiglitazone

Last Answer : C. Repaglinide

The 1st phase of insulin release from pancreatic β cells is augmented by: A. Glibenclamide B. Metformin C. Nateglinide D. Both 'A' and 'C'

Description : The 1st phase of insulin release from pancreatic β cells is augmented by: A. Glibenclamide B. Metformin C. Nateglinide D. Both 'A' and 'C'

Last Answer : C. Nateglinide

Insulin release from pancreatic β cells is augmented by the following except: A. Ketone bodies B. Glucagon C. Vagal stimulation D. Alfa adrenergic agonists

Description : Insulin release from pancreatic β cells is augmented by the following except: A. Ketone bodies B. Glucagon C. Vagal stimulation D. Alfa adrenergic agonists

Last Answer : D. Alfa adrenergic agonist

Glucagon activates the enzyme adenylcyclase which causes the increase of blood sugar level. Hence this hormone is called (A) Hypoglycemic factor (B) Hyper glycemic factor (C) Antidiauritic factor (D) Thyrotropin-releasing factor

Description : Glucagon activates the enzyme adenylcyclase which causes the increase of blood sugar level. Hence this hormone is called (A) Hypoglycemic factor (B) Hyper glycemic factor (C) Antidiauritic factor (D) Thyrotropin-releasing factor

Last Answer : Answer : B

Thyrotropin releasing hormone is a (A) Dipeptide (B) Tripeptide (C) Octapeptide (D) Decapeptide

Description : Thyrotropin releasing hormone is a (A) Dipeptide (B) Tripeptide (C) Octapeptide (D) Decapeptide

Last Answer : Answer : B

All the following statements about thyrotropin releasing hormone are true except (A) It is secreted by hypothalamus (B) It is a pentapeptide (C) It increases the secretion of TSH (D) Its secretion is inhibited by high level of T3 and T4 in blood

Description : All the following statements about thyrotropin releasing hormone are true except (A) It is secreted by hypothalamus (B) It is a pentapeptide (C) It increases the secretion of TSH (D) Its secretion is inhibited by high level of T3 and T4 in blood

Last Answer : Answer : B

Indications of somatostatin include: A. Macroprolactinoma B. Zollinger Ellison syndrome C. Bleeding esophageal varices D. Steatorrhoea

Description : Indications of somatostatin include: A. Macroprolactinoma B. Zollinger Ellison syndrome C. Bleeding esophageal varices D. Steatorrhoea

Last Answer : C. Bleeding esophageal varices

The α-cells of pancreas islets produce (A) Insulin (B) Glucagon (C) Somatostatin (D) Pancreatic polypeptide

Description : The α-cells of pancreas islets produce (A) Insulin (B) Glucagon (C) Somatostatin (D) Pancreatic polypeptide

Last Answer : Answer : B

β-cells of islet of langerhans of the pancreas secrete (A) Insulin (B) Glucagon (C) Somatostatin (D) Pancreatic polypeptide

Description : β-cells of islet of langerhans of the pancreas secrete (A) Insulin (B) Glucagon (C) Somatostatin (D) Pancreatic polypeptide

Last Answer : Answer : A

α Cells of Islets of Langerhans secrete (A) Insulin (B) Glucagon (C) Somatostatin (D) Cholecystokinin

Description : α Cells of Islets of Langerhans secrete (A) Insulin (B) Glucagon (C) Somatostatin (D) Cholecystokinin

Last Answer : Answer : B

The secretion of insulin is stimulated by: a. adrenaline b. somatostatin c. fatty acids d. acetylcholine

Description : The secretion of insulin is stimulated by: a. adrenaline b. somatostatin c. fatty acids d. acetylcholine

Last Answer : fatty acids

Which one of the following pairs of hormones are the examples of those that can easily pass through the cell membrane of the target cell and bind to a receptor inside it (mostly in the nucleus)?(a) Insulin, glucagon (b) Thyroxine, insulin (c) Somatostatin, oxytocin (d) Cortisol, testosterone

Description : Which one of the following pairs of hormones are the examples of those that can easily pass through the cell membrane of the target cell and bind to a receptor inside it (mostly in the nucleus)? (a) Insulin, glucagon (b) Thyroxine, insulin (c) Somatostatin, oxytocin (d) Cortisol, testosterone

Last Answer : (d) Cortisol, testosterone

Which one of the following pairs is incorrectly matched? (a) Glucagon – Beta cells (source) (b) Somatostatin – Delta cells (source) (c) Corpus luteum – Relaxin (secretion) (d) Insulin – Diabetes mellitus (disease

Description : Which one of the following pairs is incorrectly matched? (a) Glucagon – Beta cells (source) (b) Somatostatin – Delta cells (source) (c) Corpus luteum – Relaxin (secretion) (d) Insulin – Diabetes mellitus (disease

Last Answer : (a) Glucagon – Beta cells (source)

81. Which one of the following pairs of hormones are the examples of those that can easily pass through the cell membrane of the target cell and bind to a receptor inside it (mostly in the nucleus) (1) Cortisol, testosterone (2) Insulin, glucagon (3) Thyroxin, Insulin (4) Somatostatin, oxytocin

Description : 81. Which one of the following pairs of hormones are the examples of those that can easily pass through the cell membrane of the target cell and bind to a receptor inside it (mostly in the nucleus) (1) Cortisol, testosterone (2) Insulin, glucagon (3) Thyroxin, Insulin (4) Somatostatin, oxytocin

Last Answer : Cortisol, testosterone

6.9 For therapeutic use, growth hormone is obtained from: A. Recombinant DNA technique B. Human cadaver pituitaries C. Porcine pituitaries D. Chemical synthesis

Description : 6.9 For therapeutic use, growth hormone is obtained from: A. Recombinant DNA technique B. Human cadaver pituitaries C. Porcine pituitaries D. Chemical synthesis

Last Answer : A. Recombinant DNA technique

Plant hormone that inhibits the growth of plants. -Biology

Description : Plant hormone that inhibits the growth of plants. -Biology

Last Answer : answer:

Antidiuretic hormone (ADH) - (1) inhibits the secretion of growth hormone by the pituitary (2) inhibits the rate of heart beat (3) causes the muscular walls of the arterioles to contract that simulates the reabsorption of water from the kidney tubules (4) causes an increase in the blood pressure

Description : Antidiuretic hormone (ADH) - (1) inhibits the secretion of growth hormone by the pituitary (2) inhibits the rate of heart beat (3) causes the muscular walls of the arterioles to contract that simulates the reabsorption of water from the kidney tubules (4) causes an increase in the blood pressure

Last Answer : (3) causes the muscular walls of the arterioles to contract that simulates the reabsorption of water from the kidney tubules

Which one of the following is a feature of the VIPoma syndrome? 1) Alkalosis 2) Hypoglycaemia 3) Hypokalaemia 4) Increased gastric acid seceretion 5) Provocation of VIP release by somatostatin

Description : Which one of the following is a feature of the VIPoma syndrome? 1) Alkalosis 2) Hypoglycaemia 3) Hypokalaemia 4) Increased gastric acid seceretion 5) Provocation of VIP release by somatostatin

Last Answer : Answers-3 a, b,d,e: All opposite to what is expected. VIPOMA -Features vasoactive intestinal polypeptide secreting tumour, mainly pancreas rarely ganglioneuroblatoma (sympathetic ... -peripheral vasodilation - inhibits gastric acid secretion -potentiates acetylcholine action on salivary glands

Potassium metabolism is regulated by the hormone: (A) Aldosterone (B) PTH (C) Somatostatin (D) Estrogen

Description : Potassium metabolism is regulated by the hormone: (A) Aldosterone (B) PTH (C) Somatostatin (D) Estrogen

Last Answer : Answer : A

Which of one of the following is released by hypothalamus? (A) Somatostatin (B) Somatotropic hormone (C) Somato medin C (D) Luteinising hormone

Description : Which of one of the following is released by hypothalamus? (A) Somatostatin (B) Somatotropic hormone (C) Somato medin C (D) Luteinising hormone

Last Answer : Answer : A

16.17 Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Description : 16.17 Superactive GnRH agonists cause: A. Initial as well as sustained release of gonadotropins B. Initial inhibition followed by stimulation of gonadotropin release after 1-2 weeks C. Initial ... release after 1-2 weeks D. Initial as well as sustained inhibition of gonadotropin release

Last Answer : C. Initial stimulation followed by inhibition of gonadotropin release after 1-2 weeks

16.11 Bromocriptine causes the following: A. Prolactin release B. Vomiting C. Uterine contraction D. Impotence

Description : 16.11 Bromocriptine causes the following: A. Prolactin release B. Vomiting C. Uterine contraction D. Impotence

Last Answer : B. Vomiting

16.20 Adrenocorticotropic hormone is primarily used for: A. Treatment of Addison’s disease B. Treatment of congenital adrenal hyperplasia C. Treatment of autoimmune diseases D. Diagnosis of pituitary-adrenal axis disorders

Description : 16.20 Adrenocorticotropic hormone is primarily used for: A. Treatment of Addison’s disease B. Treatment of congenital adrenal hyperplasia C. Treatment of autoimmune diseases D. Diagnosis of pituitary-adrenal axis disorders

Last Answer : D. Diagnosis of pituitary-adrenal axis disorders

16.15 The hypothalamic gonadotropin releasing hormone (GnRH) is: A. A single peptide B. A mixture of two distinct peptides FSH-RH and LH-RH C. A mixture of several peptides D. Dopamine

Description : 16.15 The hypothalamic gonadotropin releasing hormone (GnRH) is: A. A single peptide B. A mixture of two distinct peptides FSH-RH and LH-RH C. A mixture of several peptides D. Dopamine

Last Answer : A. A single peptide

Select the drug which directly inhibits HIV-reverse transcriptase without the need for intracellular activation by phosphorylation: A. Nelfinavir B. Nevirapine C. Stavudine D. Didanosine

Description : Select the drug which directly inhibits HIV-reverse transcriptase without the need for intracellular activation by phosphorylation: A. Nelfinavir B. Nevirapine C. Stavudine D. Didanosine

Last Answer : B. Nevirapine

Zidovudine inhibits the following virus/viruses: A. Human immunodeficiency virus B. Cytomegalovirus C. Hepatitis B virus D. Both 'A' and 'B'

Description : Zidovudine inhibits the following virus/viruses: A. Human immunodeficiency virus B. Cytomegalovirus C. Hepatitis B virus D. Both 'A' and 'B'

Last Answer : A. Human immunodeficiency virus